Navigation Links
Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Date:11/20/2012

HAYWARD, Calif., Nov. 20, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced that Paul F. Truex, Anthera's President and Chief Executive Officer, will present at the Piper Jaffray Health Care Conference in New York, NY on Tuesday, November 27, 2012, at approximately 3:30 pm Eastern Time.

Piper Jaffray Health Care Conference Presentation
Date/Time: Tuesday, November 27, at 3:30 pm Eastern Time
Location: The New York Palace

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., bnery@anthera.com or 510.856.5586.


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
2. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
3. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
4. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
5. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
6. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
7. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
9. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
10. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
11. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... India and PRINCETON, N.J. ... Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: ... subsidiaries or associate companies) today announced that several ... clinical trials (reSURFACE 1 and 2) of tildrakizumab, ... treatment of moderate-to-severe plaque psoriasis, will be presented ...
(Date:3/1/2017)... March 1, 2017  The Board of Directors of ... Turfe as the new CEO and Chairman of ... of long-time Chairman and CEO William R. Cobb ... nationwide search, and brings a wealth of experience in ... "In a pool of incredibly qualified ...
(Date:3/1/2017)... March 1, 2017 Lo stesso sistema sara, visibile nello ... Paramed Medical Systems sta installando la settima unità MROpen in ... nel nuovo centro dell,European Scanning Center (ESC) a Cardiff. ESC attualmente gestisce altri ... Manchester. Continue Reading ... ...
Breaking Medicine Technology:
(Date:3/1/2017)... (PRWEB) , ... March 01, ... ... Association (ACMA) is pleased to announce the release of its 2017 update ... for case management staff and physician advisors. , Suitable for standardizing both ...
(Date:3/1/2017)... ... ... Expert on international living and leading a healthy lifestyle, Alina Reyzelman, announced ... Go app is the ultimate strategic compass that helps users to achieve goals in ... to work smarter, not harder, that's why Time & Go app provides tools and ...
(Date:3/1/2017)... ... ... “There is Comfort for the Soul”: a loving account of a very ... together, and the soul-healing comfort provided by God’s presence in the face of deep ... A. Tau, a dog-loving medical professional whose work takes her to remote areas in ...
(Date:3/1/2017)... ... 2017 , ... “Our Pure Need of Obedience to the Law of God”: a message about ... Need of Obedience to the Law of God” is the creation of published author Brent ... his wife, Anika, and children have since dedicated their lives to spreading God’s word both ...
(Date:2/28/2017)... CA (PRWEB) , ... February 28, 2017 , ... Answering ... Area, Orthogonal LLC will open a branch office in the Soma neighborhood ... growing Bay Area staff human factors, FDA regulatory and software systems architecture subject matter ...
Breaking Medicine News(10 mins):